Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cynapsus

Cynapsus
2004 FOUNDED
M&A STATUS
21-30 EMPLOYEES
M&A LATEST DEAL TYPE
10 FINANCING ROUNDS
1 INVESTMENTS
Description

Operator of a specialty central nervous system (CNS) pharmaceutical company. The company develops a sublingual thin film for the potential treatment for on-demand management of debilitating OFF episodes associated with Parkinson's disease. It also completed a Phase two clinical trial for its product candidate, APL-130277, a sublingual formulation of apomorphine hydrochloride, or apomorphine.

Website
Formerly Known As
Cannasat Therapeutics
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
  • 828 Richmond Street West
  • Toronto, Ontario M6J 1C9
  • Canada

Cynapsus Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Cynapsus‘s full profile, request access.

Request full access to PitchBook

Cynapsus Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Axovant Sciences Formerly VC-backed New York, NY 00 00000 00000000 00000
000000000000 00000 Corporate Backed or Acquired Trevose, PA 000 00000 00000000000 00000
00000000 Formerly VC-backed Durham, NC 00 00000 000000000 00000
000000 0000 000000 Formerly PE-Backed New York, NY 00 000.00 000000 - 000 000.00
00000000 000000000 Formerly VC-backed Coral Gables, FL 00 000.00 00000000 000.00
To view this company’s complete list of competitors, request access »

Cynapsus Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000000 22-Dec-2011 000000000000000000 00.00 Pharmaceuticals 00000000 00000000
To view this company’s complete investment and acquisition history, request access »

Cynapsus Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Cynapsus‘s full profile, request access.

Request full access to PitchBook

Cynapsus Executive Team (6)

Name Title Board
Seat
Contact
Info
Anthony Giovinazzo President, Chief Executive Officer and Director
Andrew Williams Co-Founder, Chief Operating Officer & Chief Financial Officer
Thierry Bilbault Ph.D Chief Scientific Officer & Executive Vice President, CMC
Albert Agro Ph.D Chief Medical Officer

2 Former Executives

You’re viewing 4 of 6 executives. Get the full list »

Cynapsus Board Members (10)

Name Representing Role Since Contact
Info
0000000 0000000000 Cynapsus President, Chief Executive Officer and Director 000 0000
000000000 00000000 Self Board Member 000 0000
000 0000000000 Cynapsus Board Member 000 0000
00000 00000000 00 Cynapsus Board Member 000 0000
00000000 00000000 Cynapsus Chairman 000 0000

2 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »